Back to Companies
Verona Pharma plc
VRNACIK: 0001657312
Verona Pharma plc (VRNA) shows 30 recent insider filings from 14 insiders, with all of them on the sell side. With $0 in purchases and $7.1M in sales, the recent tape is heavily weighted toward selling (net sales of $7.1M). Fisher Andrew (General Counsel) is the most active by dollar volume, and the single largest transaction was $4.5M by Fisher Andrew. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$21.3M
Purchases
$0
Sales
$7.1M
Unique Insiders
14
Recent Insider Trades
30 loaded
| Oct 8 | VRNA Verona Pharma plc | Deschamps Lisa | Director | Exercise | $870.8K |
| Oct 8 | VRNA Verona Pharma plc | ACKERMANN CHRISTINA | Director | Exercise | $736.5K |
| Oct 8 | VRNA Verona Pharma plc | Sinha Vikas | Director | Exercise | $770.2K |
| Oct 8 | VRNA Verona Pharma plc | EBSWORTH DAVID R | Director | Exercise | $0 |
| Oct 8 | VRNA Verona Pharma plc | Cunningham Kenneth | Director | Exercise | $870.8K |
| Oct 8 | VRNA Verona Pharma plc | Brady James Aloysius | Director | Exercise | $894.0K |
| Oct 8 | VRNA Verona Pharma plc | Fisher Andrew | General Counsel | Exercise | $4.5M |
| Oct 8 | VRNA Verona Pharma plc | Edwards Martin | Director | Exercise | $870.8K |
| Oct 8 | VRNA Verona Pharma plc | Ullman Anders | Director | Exercise | $870.8K |
| Oct 8 | VRNA Verona Pharma plc | SHAH MAHENDRA | Director | Exercise | $870.8K |
| Sep 3 | VRNA Verona Pharma plc | Rickard Kathleen A. | Chief Medical Officer | Gift | $0 |
| Sep 3 | VRNA Verona Pharma plc | ZACCARDELLI DAVID | President and CEO, Director | Gift | $0 |
| Aug 5 | VRNA Verona Pharma plc | SHAH MAHENDRA | Director | Sell | $47.4K |
| Aug 5 | VRNA Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Sell | $2.7M |
| Aug 5 | VRNA Verona Pharma plc | ACKERMANN CHRISTINA | Director | Sell | $23.8K |
| Aug 5 | VRNA Verona Pharma plc | EBSWORTH DAVID R | Director | Sell | $25.0K |
| Aug 5 | VRNA Verona Pharma plc | Cunningham Kenneth | Director | Sell | $142.1K |
| Aug 5 | VRNA Verona Pharma plc | Fisher Andrew | General Counsel | Sell | $126.0K |
| Aug 5 | VRNA Verona Pharma plc | Brady James Aloysius | Director | Sell | $10.8K |
| Aug 5 | VRNA Verona Pharma plc | Rickard Kathleen A. | Chief Medical Officer | Sell | $766.8K |
| Aug 5 | VRNA Verona Pharma plc | Ullman Anders | Director | Exercise | $0 |
| Aug 5 | VRNA Verona Pharma plc | Edwards Martin | Director | Sell | $142.1K |
| Aug 5 | VRNA Verona Pharma plc | Sinha Vikas | Director | Sell | $56.9K |
| Aug 5 | VRNA Verona Pharma plc | Austwick Michael | Director | Sell | $148.4K |
| Aug 5 | VRNA Verona Pharma plc | Deschamps Lisa | Director | Sell | $124.4K |
| Aug 5 | VRNA Verona Pharma plc | ZACCARDELLI DAVID | President and CEO, Director | Sell | $2.7M |
| Jul 9 | VRNA Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Exercise | $1.0M |
| Jul 9 | VRNA Verona Pharma plc | ZACCARDELLI DAVID | President and CEO, Director | Exercise | $1.0M |
| Jul 9 | VRNA Verona Pharma plc | Fisher Andrew | General Counsel | Exercise | $451.5K |
| Jul 9 | VRNA Verona Pharma plc | Rickard Kathleen A. | Chief Medical Officer | Exercise | $430.4K |
30 filings